(Q40963778)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8748377%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

review article

1 reference

title

The neurobiology of anxiety disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8748377%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference

Johnson MR

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8748377%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

Lydiard RB

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8748377%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

publication date

1 December 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8748377%20AND%20SRC:MED&resulttype=core&format=json

Psychiatric Clinics of North America

18 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8748377%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8748377%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

page(s)

681-725

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8748377%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8748377%20AND%20SRC:MED&resulttype=core&format=json

Blunted growth hormone response to clonidine in patients with generalized anxiety disorder

18 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Prolactin response to dl-fenfluramine in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Biological correlates of lactate sensitivity in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Lactate- and isoproterenol-induced panic attacks in panic disorder patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Seasonal Variation of Serotonin Function in Humans Research and Clinical Implications

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Adrenergic status in anxiety disorders: platelet alpha 2-adrenergic receptor binding, blood pressure, pulse, and plasma catecholamines in panic and generalized anxiety disorder patients and in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Serotonin function in panic disorders. The effect of intravenous tryptophan in healthy subjects and patients with panic disorder before and during alprazolam treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

The diagnostic utility of lactate sensitivity in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Response to lactate infusion in generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Lactate vulnerability after alprazolam versus placebo treatment of panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Slow wave sleep and 5-HT2 receptor sensitivity in generalised anxiety disorder: a pilot study with ritanserin

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Brain perfusion abnormalities in drug-naive, lactate-sensitive panic patients: a SPECT study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Recent advances in the psychopharmacology of social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Measurement of lactate-induced panic and anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

PET images of blood flow changes during anxiety: correction.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Cerebrospinal fluid levels of monoamine metabolites in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Decreased density of benzodiazepine receptors in lymphocytes of anxious patients: reversal after chronic diazepam treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Temporal lobe abnormalities in panic disorder: an MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Regional cerebral blood flow during experimental phobic fear.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Lactate vulnerability of remitted panic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Acute reversal of flunitrazepam effects by Ro 15-1788 and Ro 15-3505: inverse agonism, tolerance, and rebound.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Lactate and hyperventilation substantially attenuate vagal tone in normal volunteers. A possible mechanism of panic provocation?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Anger and anxiety responses to m-chlorophenylpiperazine in generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Ventilatory physiology of patients with panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Drug treatment of social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

A neuroanatomical hypothesis for panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Anxiogenic effects of CO2 and hyperventilation in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

High-dose carbon dioxide challenge test in anxiety disorder patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Specific sensitivity of patients with panic attacks to carbon dioxide inhalation.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

The effect of anxiety on cortical cerebral blood flow and metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Fenfluramine, cortisol, and anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Provocation of panic: three elements of the panic reaction in four anxiety disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Plasma and CSF HVA levels in panic patients with comorbid social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Serotonergic function in panic disorder: endocrine responses to D-fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Behavioral indications for serotonin receptor hypersensitivity in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

CSF dopamine levels correlate with extraversion in depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Lactate sensitivity in sleeping panic disorder patients and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Cardiac and respiratory activity in panic disorder: effects of sleep and sleep lactate infusions.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Computed axial brain tomography in long-term benzodiazepine users

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

EEG and CT findings in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

5-HT1A receptor-effector system responsivity in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

MAOIs: impact on social behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Specificity of lactate infusions in social phobia versus panic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Changes in Peripheral Benzodiazepine Receptors in Patients with Panic Disorder and Obsessive-Compulsive Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Cerebral blood flow changes induced by CO2 in anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Catecholamines and anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Catechol-O-methyltransferase and catecholamines in anxiety and relaxation.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Effects of age and gender on CNS serotonergic responsivity in normal adults

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

The effects of early postnatal handling on hippocampal glucocorticoid receptor concentrations: temporal parameters.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Positron emission tomographic evaluation of cerebral blood flow during state anxiety in simple phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Generalized anxiety disorder: some biochemical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Adrenergic function in patients with panic anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Altered central alpha 2-adrenoceptor sensitivity in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

The effect of anxiety induction on the regional uptake of 99mTc-exametazime in simple phobia as shown by single photon emission tomography (SPET).

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Correlation of severity of panic disorder and neuroanatomical changes on magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Epinephrine infusions in patients with social phobia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Carbon dioxide hypersensitivity, hyperventilation, and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Diagnostic and substance specificity of carbon-dioxide-induced panic.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Carbon dioxide/oxygen challenge test in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Laboratory response of patients with panic and obsessive-compulsive disorders to 35% CO2 challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Dopaminergic function in panic disorder: Comparison with major and minor depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Isoproterenol-induced panic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Psychological factors influencing the affective response to biological challenge procedures in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Cognitive mediation in the affective component of spontaneous panic attacks.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Response to hyperventilation and inhalation of 5.5% carbon dioxide-enriched air across the DSM-III-R anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

A positron emission tomographic study of simple phobic symptom provocation.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

II. New evidence for a locus coeruleus-norepinephrine connection with anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

The application of positron emission tomography to the study of panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Neuroanatomical correlates of a lactate-induced anxiety attack

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Positron emission tomographic studies of perceptual tasks.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Blockade by imipramine or desipramine of panic induced by sodium lactate

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Reduced benzodiazepine sensitivity in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Neuroendocrine effects of diazepam in panic and generalized anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Preliminary evidence of benzodiazepine subsensitivity in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Plasma HVA and anxiety in patients with panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Five percent carbon dioxide challenge: valid analogue and marker of panic disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

The influence of an illusion of control on panic attacks induced via inhalation of 5.5% carbon dioxide-enriched air.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Carbon dioxide inhalation reduces the function of GABAA receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Plasma biogenic amine levels in agoraphobia with panic attacks.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Noradrenergic function in generalized anxiety disorder, major depressive disorder, and healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Psychobiologic research in post-traumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Heart rate and plasma norepinephrine responsivity to orthostatic challenge in anxiety disorders. Comparison of patients with panic disorder and social phobia and normal control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Autonomic responsivity in generalized social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Lack of efficacy of the adenosine reuptake inhibitor dipyridamole in the treatment of anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Fluoxetine treatment of social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Cerebral blood flow changes during sodium-lactate-induced panic attacks.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Blunted growth hormone responses to growth hormone-releasing factor and to clonidine in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Differential responses to anxiogenic challenge studies in patients with major depressive disorder and panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Panic attack frequency and vulnerability to anxiogenic challenge studies

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Cortisol response during different anxiogenic challenges in panic disorder patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Fenfluramine provocation of anxiety in patients with panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Blunted growth hormone response to clonidine in panic disorder patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Cerebral ventricular size in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Behavioral and physiologic effects of short-term and long-term administration of clonidine in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Cognitive determinants of lactate-induced anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

A 35% carbon dioxide challenge in simple phobias.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Serotonin function in panic disorder: effect of 1-5-hydroxytryptophan in patients and controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

A functional cerebral response to frightening visual stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Carbon dioxide-induced anxiety. Behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Behavioral, biochemical, and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Yohimbine alters regional cerebral blood flow in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

PET in generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Sodium lactate infusions after treatment with tricyclic antidepressants: behavioral and physiological findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

Anxiety and cerebral blood flow during behavioral challenge. Dissociation of central from peripheral and subjective measures.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2818%2930019-4

7 January 2021

10.1016/S0193-953X(18)30019-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8748377%20AND%20SRC:MED&resulttype=core&format=json

18 October 2019

1 reference